|
|
||||||||
The Journal of Immunology, Vol 154, Issue 11 5842-5850, Copyright © 1995 by American Association of Immunologists
ARTICLES |
CM Snapper, MA Moorman, FR Rosas, MR Kehry, CR Maliszewski and JJ Mond
Department of Pathology, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
Sort-purified resting murine B cells proliferate in response to dextran- conjugated anti-IgD Abs (alpha delta-dex) but fail to secrete significant amounts of Ig even after the addition of IL-1 + IL-2. We show that either IL-3 or granulocyte-macrophage CSF (GM-CSF) stimulates 10- to 50-fold enhancements in IgM secretion by sort-purified B cells treated with alpha delta-dex + IL-1 + IL-2, and that the combined actions of IL-3 and GM-CSF are typically greater than additive. Both IL- 3 and GM-CSF act primarily as B cell differentiation factors, although IL-3 induces a modest enhancement in cellular outgrowth. The enhancing effects of IL-3 and GM-CSF require multivalent Ag receptor cross- linkage, mediated by alpha delta-dex, as neither cytokine induces IgM secretion in the presence of unconjugated anti-IgD Abs. Although both alpha delta-dex and IL-1 + IL-2 are required for optimal IL-3- and GM- CSF-mediated IgM secretion, both IL-3 and GM-CSF stimulate a modest IgM secretory response by cells activated with alpha delta-dex alone. In this regard, supernatant from either an activated CD4+ Th1 or Th2 clone potently induces IgM secretion by alpha delta-dex + IL-1 + IL-2- activated B cells and this is due, in large part, to the presence in these supernatants of either IL-3 and/or GM-CSF. Neither IL-3 nor GM- CSF stimulates significant IgM secretion by B cells activated through the CD40 signaling pathway alone, although the combination of CD40 and membrane Ig signaling leads to a strong enhancement of the IL-3 + GM- CSF-mediated IgM synthesis above that obtained with membrane Ig signaling alone. The demonstration that IL-3 and GM-CSF act directly as differentiation factors for B cells activated through their Ag receptor establishes a novel cytokine pathway for induction of humoral immunity.
This article has been cited by other articles:
![]() |
J. Riopel, M. Tam, K. Mohan, M. W. Marino, and M. M. Stevenson Granulocyte-Macrophage Colony-Stimulating Factor-Deficient Mice Have Impaired Resistance to Blood-Stage Malaria Infect. Immun., January 1, 2001; 69(1): 129 - 136. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Hou, H. Sasakj, and P. Stashenko B-Cell Deficiency Predisposes Mice to Disseminating Anaerobic Infections: Protection by Passive Antibody Transfer Infect. Immun., October 1, 2000; 68(10): 5645 - 5651. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Vos, C. M. Snapper, and J. J. Mond Th1 versus Th2 cytokine profile determines the modulation of in vitro T cell-independent type 2 responses by IL-4 Int. Immunol., September 1, 2000; 12(9): 1337 - 1345. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Harris, A. R. Pettitt, C. Schmutz, P. D. Sherrington, M. Zuzel, J. C. Cawley, and S. D. Griffiths Granuloctye-Macrophage Colony-Stimulating Factor as an Autocrine Survival Factor for Mature Normal and Malignant B Lymphocytes J. Immunol., April 1, 2000; 164(7): 3887 - 3893. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Goeckeritz, M. Flora, K. Witherspoon, Q. Vos, A. Lees, G. J. Dennis, D. S. Pisetsky, D. M. Klinman, C. M. Snapper, and J. J. Mond Multivalent cross-linking of membrane Ig sensitizes murine B cells to a broader spectrum of CpG-containing oligodeoxynucleotide motifs, including their methylated counterparts, for stimulation of proliferation and Ig secretion Int. Immunol., October 1, 1999; 11(10): 1693 - 1700. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Vos, C. M. Snapper, and J. J. Mond Heterogeneity in the ability of cytotoxic murine NK cell clones to enhance Ig secretion in vitro Int. Immunol., February 1, 1999; 11(2): 159 - 168. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wortham, L. Grinberg, D. C. Kaslow, D. E. Briles, L. S. McDaniel, A. Lees, M. Flora, C. M. Snapper, and J. J. Mond Enhanced Protective Antibody Responses to PspA after Intranasal or Subcutaneous Injections of PspA Genetically Fused to Granulocyte-Macrophage Colony-Stimulating Factor or Interleukin-2 Infect. Immun., April 1, 1998; 66(4): 1513 - 1520. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |